The mutation for medullary thyroid carcinoma with parathyroid tumors (MTC with PTs) is closely linked to the centromeric region of chromosome 10.

Two new morphs (F and G) detected by the centromeric alpha satellite probe p alpha 10RP8 and D10Z1 in HinfI digests are linked to the PstI polymorphisms of D10Z1, confirming their chromosome 10 location. The F and G morphs were in strong linkage disequilibrium with each other but were in weak linkage disequilibrium with the A and B morphs defined in PstI digests. Data for haplotypes formed by using the A and F morphs improved the lod score for linkage between the disease locus for multiple endocrine neoplasia type 2A (MEN2A) and D10Z1 (Z = 14.06 at theta = 0) in the six large families studied by Wu et al. Furthermore, the locus that codes for a distinct phenotype, medullary thyroid carcinoma (MTC) with parathyroid tumors (PTs) and no pheochromocytomas (PHEOs) (referred to as MTC with PTs), in one of the families was closely linked to two markers, D10Z1 and RBP3, with lodscores of 2.86 and 3.54, respectively, at theta = 0. A possible allelic association was noted between disease phenotypes and centromeric haplotypes. The phenotype MTC and PHEOs with and without PTs was associated with the same relatively common centromeric haplotype (A + B-F-G-) in the four families in which all four morphs could be determined, while the phenotype MTC with PTs was associated with the rare centromeric haplotype (A-B-F-G+) in one family.

[1]  A. Brooks-Wilson,et al.  A new DNA marker (D10S94) very tightly linked to the multiple endocrine neoplasia type 2A (MEN2A) locus. , 1990, American journal of human genetics.

[2]  R. Norum,et al.  Linkage of the multiple endocrine neoplasia type 2B gene (MEN2B) to chromosome 10 markers linked to MEN2A. , 1990, Genomics.

[3]  K. Kidd,et al.  The genetic defect in multiple endocrine neoplasia type 2A maps next to the centromere of chromosome 10. , 1990, American journal of human genetics.

[4]  C. Mathew,et al.  Linked markers flanking the gene for multiple endocrine neoplasia type 2A. , 1989, Genomics.

[5]  S. Baylin,et al.  The molecular biology of medullary thyroid carcinoma. A model for cancer development and progression. , 1989, JAMA.

[6]  Y. Nakamura,et al.  An extended genetic linkage map of markers for human chromosome 10. , 1988, Genomics.

[7]  H. Willard,et al.  Chromosome-specific alpha satellite DNA: isolation and mapping of a polymorphic alphoid repeat from human chromosome 10. , 1988, Genomics.

[8]  G. Lenoir,et al.  SCREENING MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A FAMILIES USING DNA MARKERS , 1988, The Lancet.

[9]  K. Kidd,et al.  Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage , 1987, Nature.

[10]  Y. Li,et al.  Bgl II RFLP recognized by a human IRBP cDNA localized to chromosome 10. , 1987, Nucleic acids research.

[11]  K. Kidd,et al.  An efficient strategy for gene mapping using multipoint linkage analysis: exclusion of the multiple endocrine neoplasia 2A (MEN2A) locus from chromosome 13. , 1987, American journal of human genetics.

[12]  H. Willard,et al.  Detection of restriction fragment length polymorphisms at the centromeres of human chromosomes by using chromosome-specific alpha satellite DNA probes: implications for development of centromere-based genetic linkage maps. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Baylin,et al.  Familial medullary thyroid carcinoma without associated endocrinopathies: A distinct clinical entity , 1986, The British journal of surgery.

[14]  N. Simpson,et al.  Multiple endocrine neoplasia, type II: a combined surgical and genetic approach to treatment. , 1981, Canadian Medical Association journal.

[15]  L. Landsberg,et al.  Measurement of urinary epinephrine in screening for pheochromocytoma in multiple endocrine neoplasia type II. , 1978, The American journal of medicine.

[16]  W. J. Dubé,et al.  Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons. , 1977, Archives of dermatology.

[17]  J. Ott Estimation of the recombination fraction in human pedigrees: efficient computation of the likelihood for human linkage studies. , 1974, American journal of human genetics.

[18]  J. Doppman,et al.  Sipple's syndrome: medullary thyroid carcinoma, pheochromocytoma, and parathyroid disease. Studies in a large family. NIH conference. , 1973, Annals of internal medicine.

[19]  A. Tashjian,et al.  Detection of medullary thyroid cancer by calcitonin assay in families. , 1972, Annals of internal medicine.

[20]  N. Morton Sequential tests for the detection of linkage. , 1955, American journal of human genetics.

[21]  P. Goodfellow,et al.  Screening for multiple endocrine neoplasia type 2A with DNA-polymorphism analysis. , 1992, Henry Ford Hospital medical journal.

[22]  R. Norum,et al.  MEN-2 tumor associations suggest a linear order of specific endocrine tumor genes. , 1989, Hormone and metabolic research. Supplement series.

[23]  K. Kidd,et al.  Closing in on the MEN2A locus. , 1989, Henry Ford Hospital medical journal.

[24]  C. Mathew,et al.  A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10 , 1987, Nature.

[25]  K. Kidd,et al.  Linkage analyses of multiple endocrine neoplasia, type 2 (MEN-2) with 23 classical genetic polymorphisms. , 1986, Human heredity.

[26]  M. Verdy,et al.  A French Canadian family with multiple endocrine neoplasia type 2 syndromes. , 1984, Henry Ford Hospital medical journal.

[27]  S. Wells,et al.  Multiple endocrine neoplasia type II. , 1976, Annual review of medicine.

[28]  H. Fudenberg,et al.  Genetic defect. , 1968, Nursing standard (Royal College of Nursing (Great Britain) : 1987).